AQR Arbitrage’s Cidara Therapeutics CDTX Stock Holding History

AQR Arbitrage’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-157,709	Closed	-$34.8M	–	564
2025 Q4	$34.8M	Buy	+157,709	New	+$25.5M	0.73%	34

AQR Arbitrage's CDTX Position: Q1 2026 in Review

AQR Arbitrage sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 157,709 shares — an estimated $34.8M sold.

AQR Arbitrage first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $34.8M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

AQR Arbitrage reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
AQR Arbitrage sold 157,709 Cidara Therapeutics shares in Q1 2026, an estimated $34.8M.
AQR Arbitrage first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
AQR Arbitrage's Cidara Therapeutics position peaked at $34.8M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.